quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·1077d
PRRelease
Impel Pharmaceuticals Inc. logo
CinCor Pharma Inc. logo

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

IMPL· Impel Pharmaceuticals Inc.CINC· CinCor Pharma Inc.
Health Care
Original source

Companies

  • IMPL
    Impel Pharmaceuticals Inc.
    Health Care
  • CINC
    CinCor Pharma Inc.
    Health Care

Recent analyst ratings

  • Dec 7CINCUpdateBarclays$22.00
  • Nov 29CINCUpdateOppenheimer-
  • Nov 29CINCUpdateMorgan Stanley$22.00
  • Oct 28CINCUpdateGoldman$67.00
  • Aug 22CINCUpdatePiper Sandler$73.00
  • Feb 1CINCUpdateEvercore ISI-

Related

  • PR540d
    Axonis Therapeutics Announces $115 Million Series A Financing
  • PR630d
    venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
  • SEC798d
    SEC Form EFFECT filed by Impel Pharmaceuticals Inc.
  • SEC799d
    SEC Form S-8 POS filed by Impel Pharmaceuticals Inc.
  • SEC799d
    SEC Form S-8 POS filed by Impel Pharmaceuticals Inc.
  • SEC799d
    SEC Form S-8 POS filed by Impel Pharmaceuticals Inc.
  • SEC799d
    SEC Form POS AM filed by Impel Pharmaceuticals Inc.
  • SEC799d
    Impel Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Bankruptcy or Receivership
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022